Kate Middleton Steps Up for Preschoolers in Powerful New Move for Kids
The early years are a crucial part of the Princess of Wales' public life, and she sees it as something she will continue with for decades to come
The new initiative is being spearheaded by two leading British children's charitiesKate Middleton's mission to help support youngsters has taken a major step.
Amid Infant Mental Health Awareness Week, the Princess of Wales' foundation announced that it is providing mental health services across an underprivileged part of London. In a groundbreaking new pilot, mental health workers will provide training and consultation to staff and families to support the social and emotional development of babies and young children in two early education settings in Tower Hamlets and Hackney. It will see around 150 babies, young children and their families supported over the year-long pilot.
"Happy Little Minds" is being spearheaded by two leading children's charities in Britain, Barnardo's and Place2Be (of which Kate is the patron). The non-profits will provide bespoke training and consultation about social and emotional development to around 50 early education practitioners at two nursery schools, classrooms that typically cater to children aged 3 and 4, in the two boroughs. They will also provide help for parents and carers, working directly with some children and families.
It is Princess Kate's lasting and ongoing mission to underscore the importance of social and emotional development for enabling babies and young children to be mentally healthy, both in the short term and in order to provide long-lasting impact for their lives. The royal mom of three is helping spread the message that the span from infancy to 5 years old is the most crucial in terms of brain development and the foundations are laid for all that is to follow.
Often, mental health problems in later life have their roots in early childhood and early intervention with babies, and Princess Kate set up the Centre for Early Childhood to funnel this work.
Christian Guy, Executive Director of The Royal Foundation Centre for Early Childhood, said in a statement, 'Early education and childcare settings can play such an important and influential role in supporting children and their families at such a vital time, in all sorts of ways."
'If settings are well-supported to promote social and emotional development in babies and young children, there is huge potential to positively impact all children, and for early intervention and prevention of future mental health conditions in those most at risk, which could be truly transformational both for individuals and society," he said.
'Place2Be and Barnardo's have such a wealth of experience to offer, and this pilot is an important step forward in understanding more about how this can be delivered to best effect," Guy added.
Can't get enough of PEOPLE's Royals coverage? to get the latest updates on Kate Middleton, Meghan Markle and more!
The idea for the new initiative started at the Shaping Us National Symposium in November 2023, when an infant mental health expert from Barnardo's had a discussion with Catherine Roche, Chief Executive of Place2Be. The pair then developed the idea and approached the Foundation for funding.
Part of the package given to staff will be The Centre for Early Childhood's The Shaping Us Framework, which she launched in February, which is aimed at improving awareness of and knowledge about social and emotional skills to inspire action across society.
In 2023, it funded a trial of an observation tool for health visitors, known internationally as the Alarm Distress Baby Scale (ADBB).
In May, Princess Kate's bid to extend the initiative into the business world also bore fruit. A collection of major companies, from NatWest Bank to IKEA and the Co-op, showed how they are rolling out programs designed to better support parents and help children thrive, such as increasing paternity leave.
Read the original article on People
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
a day ago
- New York Post
Pope Leo XIV declares a miracle at a Rhode Island hospital, says dying baby was saved by a prayer
Pope Leo XIV declared the 2007 recovery of an ailing premature baby at a Rhode Island hospital a miracle, crediting a physician's prayer with saving the baby's life, the Vatican announced. Little Tyquan Hall, who was born via emergency cesarean section, suffered from oxygen deprivation, was pale, cyanotic, and barely had a pulse — and doctors did not expect him to survive, according to the Diocese of Almeria. In a desperate plea, attending physician Dr. Juan Sanchez, a native of Huercal-Overa, Spain, prayed for the miraculous intercession of the region's patron, 19th century Father Valera Parra, WJAR reported. Advertisement Pope Leo XIV. POOL/AFP via Getty Images A few minutes after the faithful prayer the child's heart began to beat normally without medical intervention. Despite the scientifically inexplicable recovery, Tyquan was expected to have serious neurological damage due to the severe lack of oxygen in his first hours of his life. Advertisement Tyquan, however, grew up strong and hit all of his developmental milestones — including speaking at 18 months and walking at 2 years, according to WJAR. The miracle intercession declared by Pope Leo indicates that Father Valera Parra could be on the path to sainthood. Reverend Timothy Reilly of the Roman Catholic Diocese of Providence, celebrated the official declaration. 'We are thrilled that this recognition will move the cause of beatification and canonization forward for Venerable Servant of God Salvador Valera Parra,' Reilly said in a statement reported by WJAR. Advertisement Despite having hardly a pulse and being deprived of oxygen for the first hours of his life, little Tyquan Hall grew up to be a healthy baby boy. Seventyfour – 'The cool thing is, the more you think about the miracle itself, Father Valera lives in the 19th century. He never came to the U.S. We have no knowledge of him coming here. Never came to Rhode Island,' Reilly said. 'And yet, because the doctor called out and called upon his name for help in the situation back in '07 on behalf of that little baby, he decided to intervene and ask God for a miracle,' the reverend concluded, according to the outlet. Advertisement Valera Parra lived in Spain from 1816 to 1889. He was a humble diocesan priest who has had no miracles or great acts attributed to him during his lifetime. The first American pope has also pushed forward the cause of the first Millennial saint — Carlos Acutis, a charitable British 15-year-old who died in 2007 of leukemia and whose body remains uncorrupted in a glass tomb in Assis, Italy.
Yahoo
2 days ago
- Yahoo
Heart issues among endurance athletes studied by scientists
Older male endurance athletes may be at higher risk of heart scarring and related complications, according to a new study. Sudden cardiac death is a 'leading cause of mortality' in athletes, experts said as they set out to investigate whether endurance athletes had heart scarring and linked heart rhythm problems. Academics studied 106 former competitive cyclists and triathletes who exercise for more than 10 hours a week for at least 15 years. Experts from the University of Leeds scanned their hearts and had an implantable loop recorder fitted to assess their heart rhythms. They found that 50 of the 106 athletes (47%) had scarring on their hearts, particularly in the left ventricle – the main pumping chamber of the heart. This compares to 11% of 27 non endurance athletes studied for comparison. During a two-year follow up period they found that 22% of the athletes had an abnormal heart rhythm, according to the study which was funded by the the British Heart Foundation and published in the journal Circulation: Cardiovascular Imaging. They concluded that the athletes who had heart scarring were over 4.5 times more likely to experience an abnormal heart rhythm episode – which is linked with an increased risk of sudden cardiac arrest – compared to those without scarring. It is thought that among endurance athletes scarring could be caused by levels of exercise when the heart has to work even harder to pump blood. Dr Sonya Babu-Narayan, clinical director at the British Heart Foundation and consultant cardiologist, said: 'There's no doubt that exercise is good for our hearts – it helps to reduce blood pressure and cholesterol, manage our weight, and it boosts our mental health. 'But in some veteran male athletes, this early research suggests that intense exercise over many years may have affected their heart health. 'More research in veteran endurance athletes – both in men and women – will be needed to identify the small number of people who have the kind of heart scarring, together with other risk factors, that mean their life could be saved by having an implantable defibrillator.' One of the athletes who took part in the trial was Brian Cookson, keen cyclist and former president of British Cycling and Union Cycliste Internationale – cycling's world governing body. The 74-year-old grandfather from Whalley, Lancashire, said the trial could have saved his life. While training at the Manchester Velodrome he started feeling unwell and his sports watch recorded his heart rate had reached 238 beats per minute (bpm), and stayed that way for around 15 minutes. 'I was pushing it a little bit on the track, but not absolutely full gas, as we say in cycling,' Mr Cookson said. He contacted the team involved with the study who reviewed data from his implanted device to record his heart rhythm. They were able to see he had suffered an episode of ventricular tachycardia – an abnormally fast heartbeat where the heart's ventricles contract too quickly and do not pump blood around the body effectively. 'The next day, I got a call. They said, 'Stop riding your bike, don't do anything more strenuous than walking until we can get you in here because we think you need an implantable cardioverter defibrillator (ICD)',' he said. He was fitted with one of the devices in August last year which shocks the heart if it goes into an abnormal rhythm. Mr Cookson, who is still cycling, said: 'I keep a closer eye on my heart rate now and if I'm getting to 150bpm I'll start backing off. 'I'm so grateful to have been part of this study. It might well have saved my life. 'Without it, I might have carried on pushing myself until something more serious happened.' Dr Peter Swoboda, associate professor in cardiology and consultant cardiologist at the University of Leeds, who led the study, said: 'In our study, the athletes who experienced dangerous heart rhythms often had symptoms first. 'I'd encourage anyone who experiences blackouts, dizziness, chest pain or breathlessness, whether during sport or at rest, to speak to their doctor and get it checked out. 'These results shouldn't put people off regular exercise. 'Our study focused on a very select group, and not all the athletes involved were found to have scarring in their hearts. We can all benefit from being more active, and this study is an important step towards helping people take part in sport as safely as possible.' Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
3 days ago
- Business Wire
Digostics Announces University Trial of New At-home Type 1 Diabetes Test Underway
OXFORD, England--(BUSINESS WIRE)--Researchers have initiated an evaluation of a new at-home test to diagnose and monitor early stages of type 1 diabetes (T1D), based on blood glucose levels. The test would be used in individuals who have already tested positive for T1D autoantibodies to identify where they may be in their early-stage T1D progression. The trial, which is funded by Breakthrough T1D (formerly JDRF) the leading global T1D research and advocacy organization, will assess the accuracy, reproducibility, and acceptability of the GTT@home Oral Glucose Tolerance Test (OGTT) compared to in-clinic OGTTs. The results of the trial will inform future regulatory submissions for GTT@home use in T1D, which already has regulatory approval in the UK, Europe and other regions for other types of diabetes. GTT@home is an OGTT developed by British diabetes home-testing company Digostics that uses finger-prick blood samples to measure how well the body processes glucose. The test, being studied at Yale School of Medicine in New Haven, Conn., has been shown to be as accurate as lab-based OGTTs when used in adults with glucose intolerance, type 2 diabetes, or in pregnant individuals to diagnosis gestational diabetes. The GTT@home test has successfully been implemented in several UK NHS Trusts to screen for gestational diabetes in pregnancy. Dr. Jennifer Sherr, Professor of Pediatric Endocrinology and the Medical Director of Pediatric Diabetes at Yale School of Medicine and co-lead principal investigator of the trial, said: 'As the presence of diabetes autoantibodies foretells an eventual diagnosis of T1D, it is critical to conduct an OGTT to stage the disease, which helps predict the risk of progression over time. Yet, in the current paradigm this requires coming to a clinical center or laboratory and getting venous blood draws. Despite knowing there is an increased risk of diabetes many individuals struggle to undergo an OGTT for staging, or repeat the test to permit ongoing monitoring. An at-home OGTT would alleviate this barrier. The ability to have those at risk use a product that is simple, requires fingerpricks instead of venous draws, and can be done within a person's own home at a date and time that is convenient for them would be a fantastic step forward for both patients and providers.' T1D can be diagnosed at any age, and it is the most common childhood autoimmune disease, affecting around one in 350 children. In T1D the body's immune system attacks and destroys the insulin-producing cells in the pancreas, resulting in elevated blood glucose levels. It affects every aspect of health and well-being and results in lifelong insulin dependence and an increased risk of major health problems such as heart disease, blindness, and kidney failure. In 40% or more of children the diagnosis of T1D is not made until the child has become severely unwell and presents with metabolic decompensation, which is known as diabetic ketoacidosis (DKA), a life-threatening diabetes complication. Dr. Raquel Lopez-Diez, Scientist at Breakthrough T1D commented, 'Breakthrough T1D is excited to fund this important work with Yale University School of Medicine to explore an at-home alternative to OGTT for glycemic monitoring in the early stages of type 1 diabetes. Traditional in-clinic OGTTs are time-consuming, can be challenging to navigate for younger individuals, and require significant clinic resources. As new therapies emerge that can delay and, hopefully, one day prevent the progression of type 1 diabetes, it is critical to have the tools to accurately and reliably monitor and diagnose the early stages of the disease. A validated at-home testing approach would represent a major breakthrough. We look forward to seeing the results of this important study.' T1D develops in stages over time, and early stages can be detected through a simple blood test. In stage 1 the body develops islet autoantibodies but the blood glucose levels are still normal. In stage 2, islet autoantibodies are present and individuals experience abnormal blood glucose or dysglycemia, and by stage 3 an individual has the clinical diagnosis of T1D and symptoms may begin to appear due to significant loss of insulin-producing cells. The OGTT is the gold-standard test recommended for defining the stage of T1D a person is experiencing, and it is the most sensitive test for monitoring T1D stages 1 and 2. Hospital-based OGTTs are often not well tolerated because they require placement of an intravenous line inserted into the vein or multiple blood draws, as several blood samples taken over 2-hours in a healthcare setting. Study lead Dr. Alfonso Galderisi, Associate Professor of Pediatrics at Yale School of Medicine, confirmed that the study will recruit 60 patients aged eight and over. 'To understand the ease of conducting the test, participants will complete an unsupervised GTT@home test. Five to seven days later, participants will come to our research unit and we will conduct the standard of care OGTT alongside a supervised GTT@home, with the results of the two tests compared to assess accuracy. We will also be interviewing participants to assess their perception of the two methods used to conduct OGTTs.' Glucose tolerance tests are performed in the morning after an overnight fast. The GTT@home test kit contains the test device, finger prickers for blood sample collection, a preformulated glucose drink, and detailed instructions. The process begins with an initial finger prick blood sample, followed by the consumption of the glucose drink. Two hours later, a second blood sample is taken. With standard clinic-based OGTTs, individuals need to travel to a clinic early in the morning and then undergo the two blood draws two hours apart and have an IV inserted. The GTT@home device analyses blood samples shortly after completion of the test and shares results in a timely manner directly with the study teams or clinician. Expedited analysis of samples eliminates the risk of sample degradation that can affect hospital-based OGTTs when samples are not sent to the lab immediately, improving diagnostic reliability. "The support from Breakthrough T1D and the team at Yale School of Medicine underscores once again the huge potential for our at-home OGTT for use in T1D," said James Jackson, CEO and Founder of Digostics. "We are working closely with the Yale study team to support this trial.'
